| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1036353434 |
| P356 | DOI | 10.1038/GT.2011.13 |
| P698 | PubMed publication ID | 21368898 |
| P5875 | ResearchGate publication ID | 50267780 |
| P2093 | author name string | B A Bunnell | |
| J P Dufour | |||
| D S Strayer | |||
| E Marusich | |||
| J Fisher-Perkins | |||
| J-P Louboutin | |||
| P2860 | cites work | Protecting neurons from HIV-1 gp120-induced oxidant stress using both localized intracerebral and generalized intraventricular administration of antioxidant enzymes delivered by SV40-derived vectors | Q45871733 |
| Use of SV40-based vectors to transduce foreign genes to normal human peripheral blood mononuclear cells | Q45881612 | ||
| HIV-1 gp120 neurotoxicity proximally and at a distance from the point of exposure: protection by rSV40 delivery of antioxidant enzymes | Q46071543 | ||
| Adenovirus-mediated transgene expression in nonhuman primate brain | Q48201318 | ||
| Delivery of neurturin by AAV2 (CERE-120)-mediated gene transfer provides structural and functional neuroprotection and neurorestoration in MPTP-treated monkeys | Q48325968 | ||
| Rat bone marrow progenitor cells transduced in situ by rSV40 vectors differentiate into multiple central nervous system cell lineages | Q48425921 | ||
| Using gene delivery to protect HIV-susceptible CNS cells: inhibiting HIV replication in microglia. | Q48687135 | ||
| Transfer of a foreign gene into the brain using adenovirus vectors | Q64377820 | ||
| Immune responses against SIV envelope glycoprotein, using recombinant SV40 as a vaccine delivery vector | Q77148428 | ||
| Preventing HIV-1 Tat-induced neuronal apoptosis using antioxidant enzymes: mechanistic and therapeutic implications | Q79869481 | ||
| Distribution of AAV2-hAADC-transduced cells after 3 years in Parkinsonian monkeys | Q82240782 | ||
| Safety and biodistribution studies of an HSV multigene vector following intracranial delivery to non-human primates | Q28210728 | ||
| In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector | Q29547503 | ||
| Viral vectors for gene therapy in Parkinson's disease | Q32113689 | ||
| Expression of AMPA and NMDA receptor subunits in the cervical spinal cord of wobbler mice | Q33261656 | ||
| Differential transduction following basal ganglia administration of distinct pseudotyped AAV capsid serotypes in nonhuman primates | Q33731243 | ||
| Gene therapy using SV40-derived vectors: what does the future hold? | Q33755140 | ||
| Beyond the olfactory bulb: an odotopic map in the forebrain. | Q34234461 | ||
| Recombinant adeno-associated virus type 2, 4, and 5 vectors: transduction of variant cell types and regions in the mammalian central nervous system. | Q35111738 | ||
| Adenoviral vectors for gene replacement therapy | Q35882884 | ||
| Neonatal gene transfer leads to widespread correction of pathology in a murine model of lysosomal storage disease. | Q37181003 | ||
| Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector | Q37251114 | ||
| Biodistribution of adeno-associated virus type-2 in nonhuman primates after convection-enhanced delivery to brain | Q37398172 | ||
| Clinically relevant effects of convection-enhanced delivery of AAV2-GDNF on the dopaminergic nigrostriatal pathway in aged rhesus monkeys | Q37399627 | ||
| Expression, bioactivity, and safety 1 year after adeno-associated viral vector type 2-mediated delivery of neurturin to the monkey nigrostriatal system support cere-120 for Parkinson's disease | Q39863620 | ||
| Antioxidant enzyme gene delivery to protect from HIV-1 gp120-induced neuronal apoptosis | Q40251050 | ||
| Gene therapy for human alpha1-antitrypsin deficiency in an animal model using SV40-derived vectors | Q40504864 | ||
| Targeted transduction patterns in the mouse brain by lentivirus vectors pseudotyped with VSV, Ebola, Mokola, LCMV, or MuLV envelope proteins | Q40583034 | ||
| Inhibition of HIV-1 in the central nervous system by IFN-alpha2 delivered by an SV40 vector. | Q40625143 | ||
| Lentivirally delivered glial cell line-derived neurotrophic factor increases the number of striatal dopaminergic neurons in primate models of nigrostriatal degeneration. | Q40723341 | ||
| A replication-deficient rSV40 mediates liver-directed gene transfer and a long-term amelioration of jaundice in gunn rats | Q40845754 | ||
| Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease | Q40846012 | ||
| Decreased lysosomal storage in the adult MPS VII mouse brain in the vicinity of grafts of retroviral vector-corrected fibroblasts secreting high levels of β-glucuronidase | Q41102578 | ||
| Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain | Q42280576 | ||
| Morphine-induced changes in delta opioid receptor trafficking are linked to somatosensory processing in the rat spinal cord. | Q42463227 | ||
| Efficient CNS gene delivery by intravenous injection | Q42856452 | ||
| X-linked vacuolated myopathy : TNF-alpha and IFN-gamma expression in muscle fibers with MHC class I on sarcolemma | Q42856618 | ||
| Lentiviral gene transfer to the nonhuman primate brain | Q44028201 | ||
| Reversal of pathology in the entire brain of mucopolysaccharidosis type VII mice after lentivirus-mediated gene transfer. | Q44267005 | ||
| Transgene expression, bioactivity, and safety of CERE-120 (AAV2-neurturin) following delivery to the monkey striatum | Q44631221 | ||
| Expression of Escherichia coli beta-galactosidase and rat HPRT in the CNS of Macaca mulatta following adenoviral mediated gene transfer | Q44747875 | ||
| Recombinant AAV viral vectors pseudotyped with viral capsids from serotypes 1, 2, and 5 display differential efficiency and cell tropism after delivery to different regions of the central nervous system | Q45007196 | ||
| Immunology of gene therapy with adenoviral vectors in mouse skeletal muscle. | Q45270141 | ||
| Efficient gene transfer via retrograde transport in rodent and primate brains using a human immunodeficiency virus type 1-based vector pseudotyped with rabies virus glycoprotein | Q45399638 | ||
| Convection-enhanced delivery of adeno-associated virus type 2 (AAV2) into the striatum and transport of AAV2 within monkey brain | Q45418748 | ||
| Characterization of intrastriatal recombinant adeno-associated virus-mediated gene transfer of human tyrosine hydroxylase and human GTP-cyclohydrolase I in a rat model of Parkinson's disease. | Q45756120 | ||
| Gene transfer to rodent brain with recombinant adenoviral vectors: effects of infusion parameters, infectious titer, and virus concentration on transduction volume | Q45757267 | ||
| Differential and persistent expression patterns of CNS gene transfer by an adeno-associated virus (AAV) vector | Q45769447 | ||
| Inflammatory responses and their impact on beta-galactosidase transgene expression following adenovirus vector delivery to the primate caudate nucleus | Q45861874 | ||
| Inhibiting AIDS in the central nervous system: gene delivery to protect neurons from HIV. | Q45862705 | ||
| Sustained production of beta-glucuronidase from localized sites after AAV vector gene transfer results in widespread distribution of enzyme and reversal of lysosomal storage lesions in a large volume of brain in mucopolysaccharidosis VII mice. | Q45864505 | ||
| Strategies for CNS-directed gene delivery: in vivo gene transfer to the brain using SV40-derived vectors | Q45867412 | ||
| Efficient gene transfer to hematopoietic progenitor cells using SV40-derived vectors | Q45868429 | ||
| P433 | issue | 7 | |
| P304 | page(s) | 682-691 | |
| P577 | publication date | 2011-03-03 | |
| P1433 | published in | Gene Therapy | Q15763095 |
| P1476 | title | Gene transfer to the rhesus monkey brain using SV40-derived vectors is durable and safe | |
| P478 | volume | 18 |
| Q52623530 | Blood-brain barrier abnormalities caused by HIV-1 gp120: mechanistic and therapeutic implications. |
| Q54210508 | Cre Recombinase Mediates the Removal of Bacterial Backbone to Efficiently Generate rSV40. |
| Q57300366 | Effect of dsDNA on the Assembly Pathway and Mechanical Strength of SV40 VP1 Virus-like Particles |
| Q36450108 | Gene delivery of antioxidant enzymes inhibits human immunodeficiency virus type 1 gp120-induced expression of caspases |
| Q38695385 | Generation of a Vero-Based Packaging Cell Line to Produce SV40 Gene Delivery Vectors for Use in Clinical Gene Therapy Studies. |
| Q45870327 | Intracisternal rSV40 administration provides effective pan-CNS transgene expression |
| Q96135637 | Revealing in real-time a multistep assembly mechanism for SV40 virus-like particles |
| Q26829535 | Role of Oxidative Stress in HIV-1-Associated Neurocognitive Disorder and Protection by Gene Delivery of Antioxidant Enzymes |
| Q27023715 | The glial response to intracerebrally delivered therapies for neurodegenerative disorders: is this a critical issue? |
Search more.